Brand Name : Mektovi
Marketing Authorization Holder : Array BioPharma
℞ Prescription Required
Non-english packaging - English label and English insert included. Plan in advance - allow us 7 days to ship your medicine
Manufacturer of European Mektovi: PIERRE FABRE MEDICAMENT PRODUCTION Site Progipharm, Rue du Lycée 45500 GIEN France
Mektovi is used to treat skin cancer (melanoma) in adults in combination with Braftovi (containing encorafenib). This combination may slow down or stop cancer growth.
Mektovi is recommended at a dose of 90mg daily, as 45 mg (three 15 mg tablets) twice daily (12 hours apart). In order to manage adverse reactions, dose reduction, interruption of therapy or treatment stoppage be required.
|
|
|
|
